Australia markets closed

Bristol-Myers Squibb Company (BMY.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
713.00-12.00 (-1.66%)
As of 10:48AM CST. Market open.
Currency in MXN

Valuation measures4

Market cap (intra-day) 1.48T
Enterprise value 2.34T
Trailing P/E 22.64
Forward P/E 76.92
PEG ratio (5-yr expected) 30.67
Price/sales (ttm)1.80
Price/book (mrq)4.90
Enterprise value/revenue 2.83
Enterprise value/EBITDA 24.24

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 3-30.29%
S&P500 52-week change 325.87%
52-week high 31,093.85
52-week low 3676.60
50-day moving average 3742.64
200-day moving average 3852.09

Share statistics

Avg vol (3-month) 34.59k
Avg vol (10-day) 36.05k
Shares outstanding 52.03B
Implied shares outstanding 62.04B
Float 82.02B
% held by insiders 10.10%
% held by institutions 179.17%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 444.52
Forward annual dividend yield 46.14%
Trailing annual dividend rate 32.34
Trailing annual dividend yield 30.32%
5-year average dividend yield 43.37
Payout ratio 459.84%
Dividend date 3N/A
Ex-dividend date 405 July 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -13.50%
Operating margin (ttm)19.25%

Management effectiveness

Return on assets (ttm)5.39%
Return on equity (ttm)-25.33%

Income statement

Revenue (ttm)45.53B
Revenue per share (ttm)22.21
Quarterly revenue growth (yoy)4.70%
Gross profit (ttm)N/A
EBITDA 18.17B
Net income avi to common (ttm)-6.15B
Diluted EPS (ttm)-56.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.67B
Total cash per share (mrq)4.77
Total debt (mrq)57.46B
Total debt/equity (mrq)347.21%
Current ratio (mrq)1.11
Book value per share (mrq)8.14

Cash flow statement

Operating cash flow (ttm)13.72B
Levered free cash flow (ttm)16.37B